Cost of treatment failure for major depression: Direct costs of continued treatment

Administration and Policy in Mental Health

Volumn 28, Issue 4, 2001, Pages 263-277

  Baker, C Bruce ^a   Woods, Scott W ^a  

^a Yale University School of Medicine   (United States)

Author keywords

Antidepressant treatment; Cost effectiveness; Depression; Economic simulation models; Treatment failure

Indexed keywords

ANTIDEPRESSANT AGENT; LIOTHYRONINE; LITHIUM;

ARTICLE; CALCULATION; COMMUNITY MENTAL HEALTH CENTER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEPRESSION; DRUG COST; FINANCE; HUMAN; MONEY; OBSERVATION; PRIORITY JOURNAL; TREATMENT FAILURE; UNITED STATES; UTILIZATION REVIEW;

ANTIDEPRESSIVE AGENTS; COMMUNITY MENTAL HEALTH CENTERS; DEPRESSIVE DISORDER; HEALTH EXPENDITURES; HUMANS; MODELS, ECONOMIC; PATIENT ADMISSION; PROSPECTIVE STUDIES; TREATMENT FAILURE; UTILIZATION REVIEW;

EID: 0034838828     PISSN: 0894587X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011133529649     Document Type: Article

References (28)

1. 1997 Laboratory fee schedule
2. The financial implications of starting treatment with a selective serotonin reuptake inhibitor or tricyclic antidepressant in drug-naive depressed patients
3. The economic burden of depression in 1990
4. A rating scale for depression
5. Comparison of a decision analytic model with results from a naturalistic economic trial: An application to evaluating alternative antidepressants
6. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment
7. Modelling the cost-effectiveness of the prophylactic use of SSRIs in the treatment of depression
8. Direct cost of depression: Analysis of treatment costs of paroxetine versus imipramine in Canada
9. The cost of treatment dropout in depression: A cost-benefit analysis of floxetine vs. tricyclics
10. The cost of antidepressant drug therapy failure: A study of antidepressant use patterns in a Medicaid population
11. Cost-effectiveness considerations for managed care systems: Treating depression in primary care
12. Economic analysis of treating depression with nefazadone v. imipramine
13. Use of services by persons with mental and addictive disorders: Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program
14. A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression
15. Chapter 18 Access for Medicaid beneficiaries
16. Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings
17. Modelling the cost effectiveness of antidepressant treatment in primary care
18. Day hospital crisis respite care versus inpatient care. 2. Service utilization and costs
19. Antidepressant pharmacotherapy: Cost comparison of SSRIs and TCAs
20. Treatment-resistant depression
21. Cost-sharing and the use of general medical physicians for outpatient mental health care
22. Cost-effectiveness of newer antidepressants
23. Cost effectiveness of the newer generation of antidepressants
24. Cost-effectiveness of antidepressant treatment reassessed